Evidence map›Paper›PMID 31440433›Full record

ArticlePeerJ2019

Group B

Xiaofeng Mu, Changying Zhao, Junjie Yang, Xiaofang Wei, Jiaming Zhang, Cheng Liang, Zhongtao Gai, Chunling Zhang, Dequan Zhu, Ye Wang and 1 more

Abstract read
In one paragraph

Article in PeerJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Type 2 diabetes mellitus exacerbates vaginal group BbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Re-framing the importance of Group BInfection and immunity · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaofeng Mu *Tianjin University, Academy of Medical Engineering and Translational Medicine, Tianjin, China.
Changying Zhao *Shandong Children's Microbiome Center, Qilu Children's Hospital of Shandong University, Jinan, China.
Junjie YangCollege of Life Science, Qilu Normal University, Jinan, China.
Xiaofang WeiClinical Laboratory and Core Research Laboratory; Qingdao Human Microbiome Center & Qingdao Institute of Oncology, The Affiliated Central Hospital of Qingdao University, Qingdao, China.
Jiaming ZhangSchool of Basic Medical Sciences, Shandong University, Jinan, China.
Cheng LiangSchool of Information Science and Engineering, Shandong Normal University, Jinan, China.
Zhongtao GaiShandong Children's Microbiome Center, Qilu Children's Hospital of Shandong University, Jinan, China.
Chunling ZhangClinical Laboratory and Core Research Laboratory; Qingdao Human Microbiome Center & Qingdao Institute of Oncology, The Affiliated Central Hospital of Qingdao University, Qingdao, China.
Dequan ZhuMicrobiological Laboratory; Department of Infection Management; Department of Neurosurgery, Lin Yi People's Hospital, Linyi, China.
Ye WangClinical Laboratory and Core Research Laboratory; Qingdao Human Microbiome Center & Qingdao Institute of Oncology, The Affiliated Central Hospital of Qingdao University, Qingdao, China.
Lei ZhangBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have indicated that variations in the vaginal microbiome result in symptomatic conditions. Group B

methodsA total of 22 GBS-positive, non-pregnant women and 44 matched GBS-negative women were recruited for the current study. The composition of the vaginal microbiome was profiled by sequencing the 16S rRNA genes. The microbiome diversity and variation were then evaluated.

resultsThe vaginal microbiome of the 66 subjects enrolled in the current study were compared and the results showed that GBS-positive women exhibited significant vaginal microbial differences compared with the GBS-negative women based on the analysis of similarities ( DISCUSSION: The current study addressed significant variations across the communities of the vaginal microbiome in GBS-positive and GBS-negative women in a Chinese cohort, which paves the way for a larger cohort-based clinical validation study and the development of therapeutic probiotics in the future.

Indexed as

Disease transmissionGroup B StreptococcusMicrobial colonizationVaginal microbiome

Identifiers

PMID31440433
PMCPMC6699484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.